Loading...
-
Publications
Dr. Sise’s complete bibliography is available here.
- Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis
- Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer
- Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
- Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
- The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout
- Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma
- Pyelonephritis is an Underrecognized Cause of CKD in Patients With Orthotopic Ileal Neobladder Substitution
- Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline
- AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients
- Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database
- Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
- Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease
- Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer
- Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease
- Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer
- Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
- Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study
- Brief Report: Use and Side Effects of Sodium-Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical Indications
- Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations
- Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors